Bavarian Nordic’s Chikungunya vaccine trial hits primary endpoint, posing competition to Valneva’s near-approved candidate
DENMARK — Bavarian Nordic has achieved a significant milestone in its phase 3 clinical trial for a...
Read More
Tag: Bavarian Nordic
Bavarian Nordic pays up to US$380 million for Emergent Bio’s travel vaccines
DENMARK — Bavarian Nordic, a Danish vaccine maker, has announced that it will acquire Emergent...
Read More
Bavarian Nordic’s monkeypox vaccine cleared in EU, as WHO declares emergency
EUROPE – The European Medicines Agency (EMA) has extended the approved indications of Bavarian...
Read More
J&J terminates vaccine partnership with Bavarian Nordic
USA – Johnson & Johnson has announced the termination of its collaboration and license...
Read More
LATEST DIGITAL MAGAZINE
